GenVec results for the company's Q4 and fiscal 2012 have been released. For the quarter, revenue was $1.5 million, less than half the $3.4 million of the same period the previous year. Attributable net loss deepened over that time span, to $3.2 million ($0.24 per diluted share), from Q4 2011's shortfall of $2.5 million ($0.19).

On average, analysts had anticipated revenue of $3.7 million, and a per-share loss of $0.27.

For the full year, top line was $9.5 million, far below the  2011 figure of $17.7 million. Net loss plunged further into the red, to $14.1 million ($1.09 per diluted share) for the year against 2011's $7.4 million ($0.58).

The article GenVec Q4 Net Loss Deepens originally appeared on Fool.com.

Fool contributor Eric Volkman has no position in GenVec. The Motley Fool has no position in GenVec. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.


Increase your money and finance knowledge from home

Understanding Stock Market Indexes

What does it mean when people say "the market is up 2%"?

View Course »

What are Penny Stocks

The lucrative and dangerous world of penny stocks.

View Course »

Add a Comment

*0 / 3000 Character Maximum